Narcotic Use in Patients with Crohn's Disease
Authors:
- Keith T. WilsonKWKeith T. Wilson
- David G. BinionDBDavid G. Binion
- 1 October 2005
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 100 (10) , 2225-2229
Abstract
Er a 5-yr period was performed. Clinical status was evaluated with the Harvey–Bradshaw index (HBI) of disease activity and the short inflammatory bowel disease questionnaire (SIBDQ). RESULTS Narcotic use was identified in 13.1% of patients. Narcotic users were more likely to be female, 72%versus 49% (p = 0.01), had higher rates of disability, 15.4%versus 3.6% (p = 0.001), and a longer duration of disease, 17.0 versus 12.9 yr (p = 0.03). In addition, they took more medications 6.97 versus 4.7 (p < 0.001) and had a higher prevalence of neuropsychiatric drug use, 37%versus 19% (p = 0.01). CD patients receiving narcotics had worse disease activity (HBI 9.1 vs 5.0, p < 0.001) and diminished quality of life (SIBDQ 44.2 vs 51.6 (p = 0.04)). However, logistic regression analysis found that active disease [HBI score of ≥ 4 (OR 3.9)], polypharmacy [use of ≥ 5 drugs (OR 5.5)], and smoking (OR 2.8) were associated with narcotic use. CONCLUSIONS Narcotic use may be an indicator of more severe disease since it is associated with increased disease activity and decreased quality of life. Factors correlating with narcotic use include smoking and PP. Our data emphasize the need for further work to characterize chronic pain in CD patients....Keywords
This publication has 14 references indexed in Scilit:
- Polypharmacy and Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2005
- Smoking and subsequent risk of early retirement due to permanent disabilityEuropean Journal of Public Health, 2004
- Chronic narcotic use in inflammatory bowel disease patients: Prevalence and clinical characteristicsJournal of Gastroenterology and Hepatology, 2001
- The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitisAmerican Journal of Gastroenterology, 2001
- Smoking and inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2000
- Influence of Sex and Disease on Illness‐Related Concerns in Inflammatory Bowel DiseaseCanadian Journal of Gastroenterology and Hepatology, 1999
- The Crohn’s Disease Activity Index, Its Derivatives and the Inflammatory Bowel Disease Questionnaire: A Review of Instruments to Assess in Crohn’s DiseaseCanadian Journal of Gastroenterology and Hepatology, 1999
- Polypharmacy: correlations with sex, age and drug regimenEuropean Journal of Clinical Pharmacology, 1998
- Rectal afferent function in patients with inflammatory and functional intestinal disordersPain, 1996
- Narcotic Dependence in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1988